Stanford University
Showing 14,731-14,740 of 35,031 Results
-
Ayako Kawano
Ph.D. Student in Environment and Resources, admitted Autumn 2022
BioAyako Kawano is a Ph.D. candidate at Stanford University. Her research interests include the impact analysis of air pollution on population health and climate change in low- and middle-income countries using remote sensing data and machine learning methods. Before coming to Stanford, she worked as a Data Scientist at UN Global Pulse and as a Program Manager at the United Nations Industrial Development Organization (UNIDO).
-
Dane Kawano
Ph.D. Student in Biology, admitted Autumn 2019
BioBorn and raised in Hawaii. Moved to Seattle, WA to study biology and biochemistry at the University of Washington. After graduating, I moved to Bethesda, MD to work at the NIH as an IRTA fellow. Currently in the Shen Lab studying microtubule biology in C. elegans neurons
-
Cameron S. Kay
Postdoctoral Scholar, Environmental Social Sciences
BioCameron S. Kay is a postdoctoral scholar in the Climate Cognition Lab at Stanford University. His research explores the psychological foundations of antisocial beliefs and behaviours, including why people believe in conspiracy theories, harbour prejudicial beliefs, and gaslight others. To support this work, he develops psychometrically sound scales and tools for improving data quality. Before joining Stanford, Cameron was a visiting assistant professor at Union College in Upstate New York. He earned his PhD in psychology with a specialization in quantitative research methods at the University of Oregon, where he also completed master’s degrees in psychology and journalism. He holds a BA in psychology from the University of British Columbia.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
